Cenatex Holdings LLC Increases Holdings of Bri-Chem Corp.
Cenatex Holdings LLC has increased its stake in Bri-Chem Corp. (BRYFF) through two transactions. The company purchased 500 common shares at an average price of $0.1994 USD per share, totaling $99.70 USD. Additionally, Joint Actors Barry Hugghins and related IRA accounts transferred 1,120,820 common shares to Cenatex. Following these transactions, Cenatex now owns 3,701,040 common shares, representing 14.0016% of Bri-Chem's total outstanding shares of 26,432,981.
The transfer of shares from Joint Actors was done to streamline management of holdings. Cenatex indicates it may further adjust its position in Bri-Chem based on various factors including market conditions, price, availability of shares, and company developments.
Cenatex Holdings LLC ha aumentato la sua partecipazione in Bri-Chem Corp. (BRYFF) attraverso due operazioni. La società ha acquistato 500 azioni ordinarie al prezzo medio di 0,1994 USD per azione, per un totale di 99,70 USD. Inoltre, gli Attori Congiunti Barry Hugghins e i conti IRA correlati hanno trasferito 1.120.820 azioni ordinarie a Cenatex. Dopo queste operazioni, Cenatex possiede ora 3.701.040 azioni ordinarie, che rappresentano il 14,0016% del totale delle azioni in circolazione di Bri-Chem, pari a 26.432.981.
Il trasferimento delle azioni dagli Attori Congiunti è stato effettuato per semplificare la gestione delle partecipazioni. Cenatex indica che potrebbe ulteriormente modificare la sua posizione in Bri-Chem in base a vari fattori, tra cui le condizioni di mercato, il prezzo, la disponibilità delle azioni e gli sviluppi aziendali.
Cenatex Holdings LLC ha incrementado su participación en Bri-Chem Corp. (BRYFF) mediante dos transacciones. La empresa compró 500 acciones comunes a un precio promedio de 0,1994 USD por acción, sumando un total de 99,70 USD. Además, los Actores Conjuntos Barry Hugghins y las cuentas IRA relacionadas transfirieron 1.120.820 acciones comunes a Cenatex. Tras estas transacciones, Cenatex posee ahora 3.701.040 acciones comunes, lo que representa el 14,0016% del total de acciones en circulación de Bri-Chem, que asciende a 26.432.981.
La transferencia de acciones desde los Actores Conjuntos se realizó para simplificar la gestión de las participaciones. Cenatex indica que podría ajustar aún más su posición en Bri-Chem según diversos factores, incluyendo las condiciones del mercado, el precio, la disponibilidad de acciones y los desarrollos de la empresa.
Cenatex Holdings LLC는 두 건의 거래를 통해 Bri-Chem Corp. (BRYFF)에 대한 지분을 늘렸습니다. 회사는 주당 평균 0.1994달러에 보통주 500주를 매수하여 총 99.70달러를 지출했습니다. 또한, 공동 행위자 Barry Hugghins와 관련 IRA 계좌들이 1,120,820주의 보통주를 Cenatex로 이전했습니다. 이 거래 이후 Cenatex는 총 3,701,040주의 보통주를 보유하게 되었으며, 이는 Bri-Chem의 총 발행 주식 26,432,981주의 14.0016%에 해당합니다.
공동 행위자들로부터의 주식 이전은 보유 지분 관리를 간소화하기 위해 이루어졌습니다. Cenatex는 시장 상황, 가격, 주식 가용성, 회사의 발전 상황 등 여러 요인을 고려하여 Bri-Chem에 대한 지분을 추가로 조정할 수 있음을 밝혔습니다.
Cenatex Holdings LLC a augmenté sa participation dans Bri-Chem Corp. (BRYFF) via deux transactions. La société a acheté 500 actions ordinaires à un prix moyen de 0,1994 USD par action, pour un total de 99,70 USD. De plus, les Acteurs Conjoints Barry Hugghins et les comptes IRA associés ont transféré 1 120 820 actions ordinaires à Cenatex. À la suite de ces transactions, Cenatex détient désormais 3 701 040 actions ordinaires, représentant 14,0016% du total des actions en circulation de Bri-Chem, qui s'élève à 26 432 981.
Le transfert des actions des Acteurs Conjoints a été effectué afin de simplifier la gestion des participations. Cenatex indique qu'il pourrait ajuster davantage sa position dans Bri-Chem en fonction de divers facteurs, notamment les conditions du marché, le prix, la disponibilité des actions et les évolutions de l'entreprise.
Cenatex Holdings LLC hat seinen Anteil an Bri-Chem Corp. (BRYFF) durch zwei Transaktionen erhöht. Das Unternehmen kaufte 500 Stammaktien zu einem Durchschnittspreis von 0,1994 USD pro Aktie, insgesamt 99,70 USD. Zusätzlich übertrugen die gemeinsamen Akteure Barry Hugghins und die zugehörigen IRA-Konten 1.120.820 Stammaktien an Cenatex. Nach diesen Transaktionen hält Cenatex nun 3.701.040 Stammaktien, was 14,0016% der insgesamt ausstehenden 26.432.981 Aktien von Bri-Chem entspricht.
Die Übertragung der Aktien von den gemeinsamen Akteuren erfolgte, um die Verwaltung der Beteiligungen zu vereinfachen. Cenatex gibt an, dass es seine Position bei Bri-Chem basierend auf verschiedenen Faktoren wie Marktbedingungen, Preis, Verfügbarkeit der Aktien und Unternehmensentwicklungen weiter anpassen könnte.
- Consolidated ownership structure for more efficient management of holdings
- Increased stake shows confidence in the company from major shareholder
- Small purchase size ($99.70) suggests limited immediate investment interest
- Cenatex indicates potential future share sales, creating uncertainty
Garland, Texas--(Newsfile Corp. - May 12, 2025) - Cenatex Holdings, LLC ("Cenatex"), a Texas limited liability company, purchased an aggregate of 500 common shares (the "Common Shares") in the capital of Bri-Chem Corp. ("Bri-Chem") listed on the Toronto Stock Exchange at an average price of
Immediately prior to the Purchase, Cenatex owned, or had control or direction over, an aggregate of 3,700,540 Common Shares, representing
The Joint Actors transferred their Common Shares to Cenatex so that the holdings could be more easily managed. Cenatex purchased the additional Common Shares as a result of an investment decision, and based on current market conditions, Cenatex may, in the future, further increase or decrease its shareholdings in Bri-Chem, as circumstances warrant, whether in the open market, by privately negotiated agreements, or otherwise. Any transaction that Cenatex may pursue may be made at any time, and from time to time, without prior notice, and will depend on a variety of factors, including, and without limitation, the price and availability of common shares of Bri-Chem, subsequent developments affecting Bri-Chem, its business and prospects, other investments and business opportunities available to Cenatex, general industry and economic conditions, the securities markets in general, compliance with applicable securities laws, and other factors deemed relevant by Cenatex and joint actors.
An early warning report related to this transaction will be filed on SEDAR+ under Bri-Chem's profile at www.sedarplus.ca. To obtain a copy of such report, please contact
Cecil J. Cavanaugh, CPA, at 225-715-6351 or Barry Hugghins at 225-802-2664. The main office of Cenatex is located at 7405 Ramblewood Drive, Garland, Texas 75044. The main office of Bri-Chem is located at 27075 Acheson Road, Acheson, Alberta, T7X 6B1.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251819
FAQ
What is Cenatex Holdings LLC's current ownership percentage in Bri-Chem Corp (BRYFF)?
How many shares did Cenatex Holdings purchase of BRYFF in their latest transaction?
Why did the Joint Actors transfer their Bri-Chem (BRYFF) shares to Cenatex Holdings?
What are Cenatex Holdings' future plans regarding their BRYFF shareholding?
